Compile Data Set for Download or QSAR
Report error Found 138 Enz. Inhib. hit(s) with all data for entry = 8836
TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422059(US10508103, Embodiment 1)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422060(US10508103, Embodiment 2)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422088(US10508103, Embodiment 3)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422089(US10508103, Embodiment 4)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422090(US10508103, Embodiment 5)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422091(US10508103, Embodiment 6)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422092(US10508103, Embodiment 7)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422093(US10508103, Embodiment 8)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422094(US10508103, Embodiment 9)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422095(US10508103, Embodiment 10)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422096(US10508103, Embodiment 11)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422097(US10508103, Embodiment 12)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422061(US10508103, Embodiment 13)
Affinity DataEC50: >100nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422062(US10508103, Embodiment 14)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422098(US10508103, Embodiment 15)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422063(US10508103, Embodiment 16)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422064(US10508103, Embodiment 17)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422065(US10508103, Embodiment 18)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422066(US10508103, Embodiment 19)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422067(US10508103, Embodiment 20)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422068(US10508103, Embodiment 21)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422069(US10508103, Embodiment 22)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422070(US10508103, Embodiment 23)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422071(US10508103, Embodiment 24)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422072(US10508103, Embodiment 25)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422073(US10508103, Embodiment 26)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422074(US10508103, Embodiment 27)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422075(US10508103, Embodiment 28)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422076(US10508103, Embodiment 29)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422077(US10508103, Embodiment 30)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422078(US10508103, Embodiment 31)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422079(US10508103, Embodiment 32)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422099(US10508103, Embodiment 33)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422100(US10508103, Embodiment 34)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422101(US10508103, Embodiment 35)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422080(US10508103, Embodiment 36)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422102(US10508103, Embodiment 37)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422081(US10508103, Embodiment 38)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422082(US10508103, Embodiment 39)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422083(US10508103, Embodiment 40)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422103(US10508103, Embodiment 41)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422084(US10508103, Embodiment 42)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422085(US10508103, Embodiment 43)
Affinity DataEC50: >100nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422086(US10508103, Embodiment 44)
Affinity DataEC50: >100nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422104(US10508103, Embodiment 45)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422087(US10508103, Embodiment 46)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422105(US10508103, Embodiment 47)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422106(US10508103, Embodiment 48)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422107(US10508103, Embodiment 49)
Affinity DataEC50: <10nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM422108(US10508103, Embodiment 50)
Affinity DataEC50:  55nMAssay Description:First day:Dilution of Compounds: 1) tested compounds were added into DMSO to give parent liquor (10 mM); 2) reference compound Birinapant (32 μL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 138 total ) | Next | Last >>
Jump to: